CMB 4.29% 33.5¢ cambium bio limited

I have to agree with you. That's RGS's best presentation in 2...

  1. 172 Posts.
    lightbulb Created with Sketch. 52
    I have to agree with you. That's RGS's best presentation in 2 years.
    Clear, timeframed, and above all exciting.
    One can see the critical role that Dr Blaber (who just re-joined RGS) is going to have as Clinical Director.

    This presentation makes think RGS has finally moved from R&D company only, then R&D + partnership (Kyocera) to finally a clinical biotech which has the financial resources to back their claims and discoveries.

    Impressive
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.015(4.29%)
Mkt cap ! $3.996M
Open High Low Value Volume
35.0¢ 35.5¢ 33.5¢ $61 174

Buyers (Bids)

No. Vol. Price($)
1 41 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 7905 1
View Market Depth
Last trade - 15.33pm 02/09/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.